Try our corporate solution for free!

Time from R&D start to approval of select cancer drugs 2017

Time between R&D start and approval of selected cancer drugs on the market as of 2017

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

November 2017

Region

United States

Survey time period

as of November 2017

Supplementary notes

This statistic includes only pharmaceutical companies with a single oncologic drug approved by the Food and Drug Administration (FDA).
* Alexion later had two drug approvals in the last quarter of 2015; these drugs are not included in this statistic.
** Compound acquired by the company on this date.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Oncology "

Statistics on Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

18
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.